Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy-Related Toxicity”

207 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 207 results

Not applicableLooking for participantsNCT04979078
What this trial is testing

Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction

Who this might be right for
Hand-foot SyndromeHand-foot Skin Reaction
Jessa Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT05517668
What this trial is testing

Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose

Who this might be right for
AcetaminophenDrug OverdoseAcetaminophen Overdose+4 more
Richard Dart, MD, PhD 29
Not applicableStudy completedNCT02103010
What this trial is testing

Predictive Modelling for Patient Stratification According to Treatment-related Toxicity and Survival After Chemoradiation for Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University Hospital, Ghent 45
Not applicableNot Yet RecruitingNCT07553234
What this trial is testing

Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment

Who this might be right for
Breast Cancer
University of Chicago 20
Not applicableUnknownNCT05728788
What this trial is testing

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy

Who this might be right for
Cancer Therapy-related Cardiovascular Toxicity
Peking University Third Hospital 50
Testing effectiveness (Phase 2)Study completedNCT05378360
What this trial is testing

DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities

Who this might be right for
Rash Acneiform
Daewoong Pharmaceutical Co. LTD. 96
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80
Testing effectiveness (Phase 2)WithdrawnNCT00397501
What this trial is testing

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more
OHSU Knight Cancer Institute
Not applicableLooking for participantsNCT02478931
What this trial is testing

Study of Personalized Cancer Therapy to Determine Response and Toxicity

Who this might be right for
Cancer
Shu Mei Kato 10,000
Not applicableStudy completedNCT02440620
What this trial is testing

Cardiac Toxicity in Medical Treatment of Breast Cancer

Who this might be right for
Heart FailureBreast Cancer
Odense University Hospital 45
Testing effectiveness (Phase 2)Study completedNCT01548690
What this trial is testing

Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury

Who this might be right for
Acute Liver FailureAcute Liver Injury
William Lee 47
Not applicableStudy completedNCT03948724
What this trial is testing

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Who this might be right for
Therapeutic Patient EducationImmune Checkpoint InhibitorsMelanoma+4 more
Institut Cancerologie de l'Ouest 412
Large-scale testing (Phase 3)Looking for participantsNCT06214195
What this trial is testing

The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity

Who this might be right for
Cardiotoxicity Induced by Drug Therapy for Breast Cancer
Zhejiang Cancer Hospital 276
Large-scale testing (Phase 3)Study completedNCT02987257
What this trial is testing

NATIENS: Optimal Management and Mechanisms of SJS/TEN

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolyses
Vanderbilt University Medical Center 2
Testing effectiveness (Phase 2)UnknownNCT02052102
What this trial is testing

Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart

Who this might be right for
Breast CancerAdverse Effect of Radiation Therapy
AHS Cancer Control Alberta 63
Testing effectiveness (Phase 2)UnknownNCT02036957
What this trial is testing

MARY DUOL REPAIR BALM IN THE PREVENTION OR REDUCING ANTINEOPLASIC AGENTS' SKIN TOXICITY

Who this might be right for
Dermatitis, Adverse Drug Reaction
Basque Health Service 86
Testing effectiveness (Phase 2)Study completedNCT03314805
What this trial is testing

PG2 Breast Cancer Evaluation in Adjuvant Medicine Study

Who this might be right for
Cancer-related FatigueNeutropenia, Malignant
PhytoHealth Corporation 67
Large-scale testing (Phase 3)Study completedNCT01792570
What this trial is testing

DRV/r + RPV QD: Efficacy and Toxicity Reduction

Who this might be right for
Human Immunodeficiency Virus
ASST Fatebenefratelli Sacco 37
Testing effectiveness (Phase 2)UnknownNCT00003251
What this trial is testing

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity
University of Illinois at Chicago 46
Testing effectiveness (Phase 2)Looking for participantsNCT03480971
What this trial is testing

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Who this might be right for
MucositisNephrotoxicityOtotoxicity
Matrix Biomed, Inc. 120
Next Page